Published in Vox Sang on January 01, 1992
Performance of third-generation confirmatory tests for detection of antibody to hepatitis C virus. J Clin Microbiol (1994) 0.77
Anti-HCV assays: first or second generation? Vox Sang (1993) 0.75
Application of the passive haemolysis test for the determination of rubella virus antibodies. Acta Pathol Microbiol Scand B (1975) 2.66
Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study Group. Antimicrob Agents Chemother (1993) 1.93
Pelvic inflammatory disease associated with Chlamydia trachomatis infection after therapeutic abortion. A prospective study. Br J Vener Dis (1983) 1.69
Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrum. Scand J Gastroenterol (2003) 1.63
False-negative results of a ligase chain reaction assay to detect Chlamydia trachomatis due to inhibitors in urine. Eur J Clin Microbiol Infect Dis (1997) 1.61
Therapeutic abortion and Chlamydia trachomatis infection. Br J Vener Dis (1982) 1.53
Raised serum ferritin predicts non-response to interferon and ribavirin treatment in patients with chronic hepatitis C infection. Liver (2002) 1.48
Treatment of chronic hepatitis C in injecting drug users: 5 years' follow-up. Eur Addict Res (2002) 1.35
Diagnosis of recent Herpes simplex infections. A modified immunofluorescent test for the detection of specific Herpes simplex IgM antibodies after staphylococcal adsorption of IgG. Acta Pathol Microbiol Scand B Microbiol Immunol (1974) 1.33
The diagnostic value of determination of IgM antibodies against Mycoplasma pneumoniae by the indirect immunofluorescent antibody test. Acta Pathol Microbiol Scand B (1976) 1.29
Proliferative human T cell responses to Chlamydia trachomatis in vitro. Acta Pathol Microbiol Immunol Scand C (1983) 1.19
Sensitivity of western blotting (compared with ELISA and immunofluorescence) during seroconversion after HTLV-III infection. Lancet (1986) 1.17
Comparison of the sensitivity of four rapid assays for the detection of antibodies to HIV-1/HIV-2 during seroconversion. Clin Diagn Virol (1996) 1.05
Hepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDS. AIDS (1992) 1.04
Chlamydial serum IgG antibodies in patients with acute salpingitis measured by an enzyme-linked immunosorbent assay. Acta Pathol Microbiol Immunol Scand C (1982) 1.03
Effect of combined interferon-alpha induction therapy and ribavirin on chronic hepatitis C virus infection: a randomized multicentre study. Scand J Gastroenterol (2002) 1.02
Long-term outcome of chronic hepatitis C virus infection in primary hypogammaglobulinaemia. QJM (1999) 0.97
An indirect immunofluorescent antibody test for determination of Rubella virus specific IgM antibodies. Elimination of secondary IgM rheumatoid factor staining after absorption of serum IgG with Staphylococcal protein A. Acta Pathol Microbiol Scand C (1978) 0.97
A rubella epidemic in an unvaccinated pregnant population. I. Screening methods and serological results. Scand J Infect Dis (1981) 0.97
A rotavirus staphylococcal co-agglutination test. Acta Pathol Microbiol Immunol Scand B (1983) 0.96
Relevance of a combined HIV antigen/antibody assay to detect early HIV infections in a low prevalence population: case reports. Clin Lab (2004) 0.96
An outbreak of hepatitis A among homosexuals linked to a family outbreak. Epidemiol Infect (2002) 0.93
Screening urine samples by leukocyte esterase test and ligase chain reaction for chlamydial infections among asymptomatic men. J Clin Microbiol (1995) 0.93
Correlation of growth of aerobic blood cultures in hypertonic broth with antibiotic therapy. J Clin Microbiol (1982) 0.90
Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group. Scand J Infect Dis (1997) 0.89
[Isolation and serological diagnosis of Chlamydia trachomatis in acute salpingitis]. Tidsskr Nor Laegeforen (1982) 0.88
T cell proliferative responses to Chlamydia trachomatis antigen in vitro in patients with a history of gynaecological chlamydia infection. Br J Vener Dis (1984) 0.88
Characterisation of an epidemic of hepatitis A virus involving intravenous drug abusers--infection by needle sharing? J Med Virol (1997) 0.87
The spectrum of hepatobiliary disease in primary hypogammaglobulinaemia. J Intern Med (1999) 0.86
Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT Group. Scand J Gastroenterol (1999) 0.85
Cell-mediated and humoral immune responses to chlamydial and herpesvirus antigens in patients with cervical carcinoma. Gynecol Oncol (1985) 0.83
Characterization of Chlamydia trachomatis serotypes by human T-lymphocyte clones. Scand J Immunol (1985) 0.81
Posttransfusion hepatitis B transmitted by blood from a hepatitis B surface antigen-negative hepatitis B virus carrier. Transfusion (1990) 0.81
Detection of HBV DNA by PCR in serum from an HBsAg negative blood donor implicated in cases of post-transfusion hepatitis B. Arch Virol Suppl (1992) 0.80
Chlamydial secretory IgA antibodies in human milk. Acta Pathol Microbiol Immunol Scand C (1982) 0.79
A unique hepatitis A virus strain caused an epidemic in Norway associated with intravenous drug abuse. The Hepatitis A Study Group. Scand J Infect Dis (1998) 0.79
Effect of interferon-alpha induction therapy on genotype 2b/3a and low viral load hepatitis C virus infection. A randomized multicentre study. Scand J Gastroenterol (2002) 0.79
Detection of adenovirus-specific immunoglobulin A in tears from patients with keratoconjunctivitis. Eur J Clin Microbiol (1986) 0.79
The early introduction of HIV infection among Norwegians at highest risk. Scand J Infect Dis (1990) 0.79
[Hospital admissions due to obstructive lung diseases and pneumonia in two hospital districts]. Tidsskr Nor Laegeforen (1999) 0.78
Prevalence of anti-HCV in Norwegian blood donors with anti-HBc or increased ALT levels. Transfusion (1990) 0.78
Liver transplantation for endstage hepatitis C cirrhosis in a patient with primary hypogammaglobulinaemia. Scand J Infect Dis (1998) 0.78
Cardiobacterium hominis endocarditis. Eur J Clin Microbiol (1983) 0.78
Interferon-alpha 2b therapy in low-activity hepatitis C: a pilot study. Scand J Gastroenterol (1997) 0.77
[Surveillance of hepatitis A by molecular epidemiologic studies]. Tidsskr Nor Laegeforen (1999) 0.77
Risk of toxoplasmic encephalitis in AIDS patients: indications for prophylaxis. Scand J Infect Dis (1996) 0.77
Reactivation of hepatitis B virus infection in an anti-HBc and anti-HBs positive patient after allogeneic bone marrow transplantation. Eur J Haematol (2000) 0.77
The significance of the carbohydrate constituents of bovine thrombin for the clotting activity. Biochim Biophys Acta (1971) 0.77
Varicose veins in developing countries. Lancet (1976) 0.77
The effect of treatment with alpha-interferon on hepatitis G/GBV-C viraemia. The CONSTRUCT Group. Scand J Gastroenterol (1998) 0.76
[Screening of pregnant women for toxoplasma infection]. Tidsskr Nor Laegeforen (1997) 0.75
[Immunofluorescence test in the diagnosis of AIDS-associated virus infection in Norway]. Tidsskr Nor Laegeforen (1986) 0.75
[Treatment of hepatitis C]. Tidsskr Nor Laegeforen (1996) 0.75
[An outbreak of hepatitis A among intravenous drug addicts in Oslo 1995-96]. Tidsskr Nor Laegeforen (1997) 0.75
HIV and hepatitis B infection in an international cohort of dental hygienists. Scand J Dent Res (1988) 0.75
[Electrophoresis of cerebrospinal fluid]. Nord Med (1971) 0.75
[Campylobacter - a new cause of enteritis]. Tidsskr Nor Laegeforen (1980) 0.75
Detection of GB virus C RNA by GBV-C LCx and two PCR assays with primers from the 5' non-coding and NS5B region. J Virol Methods (1998) 0.75
[Bacteremia at Ullvål Hospital 1977-1979. Types of bacteria and antibiotic sensitivity]. Tidsskr Nor Laegeforen (1981) 0.75
A rubella epidemic in an unvaccinated pregnant population. 2. Seroepidemiology. Scand J Infect Dis (1981) 0.75
Two dose regimens of recombinant interferon-alpha-2b in chronic hepatitis C virus infection. Biochemistry, hepatitis C virus RNA, and liver histology as response indices. Scand J Gastroenterol (1995) 0.75
[Anti-HIV serology today. Specificity, sensitivity and predictive value]. Tidsskr Nor Laegeforen (1988) 0.75
HIV infection in Norwegian haemophiliacs: the prevalence of antibodies against HIV in haemophiliacs treated with lyophilized cryoprecipitate from volunteer donors. Eur J Haematol (1987) 0.75
[Viral hepatitis and blood transfusion]. Tidsskr Nor Laegeforen (1991) 0.75
[Tularemia after tick bite in Vestfold]. Tidsskr Nor Laegeforen (1998) 0.75
[Mycoplasma hominis salpingitis. A serological study]. Tidsskr Nor Laegeforen (1985) 0.75
[HTLV examination of Norwegian blood donors]. Tidsskr Nor Laegeforen (1999) 0.75
[Chronic hepatitis C. Experience with 50 patients]. Tidsskr Nor Laegeforen (1992) 0.75
[Hepatitis C virus among pregnant women in Norway--occurrence of antibodies and pregnancy outcome]. Tidsskr Nor Laegeforen (2000) 0.75
Hysterosalpingography: value in estimating tubal function, and risk of infectious complications. Acta Eur Fertil (1985) 0.75
[Acute HIV disease]. Tidsskr Nor Laegeforen (1988) 0.75
[Anti-hepatitis C (HCV) ELISA. A serologic test for non-A non-B hepatitis (NANBH) after blood transfusion]. Tidsskr Nor Laegeforen (1989) 0.75
[Tuberculosis among HIV-infected persons in Norway]. Tidsskr Nor Laegeforen (2001) 0.75
Treatment of Salmonella carriers with pivmecillinam alone or in combination with pivampicillin: experience with three patients. Scand J Infect Dis (1983) 0.75
[Endemic typhus imported to Norway]. Tidsskr Nor Laegeforen (1997) 0.75
[Fungemia. Case records from Ullevål Hospital]. Tidsskr Nor Laegeforen (1983) 0.75
[Q-fever imported into Norway]. Tidsskr Nor Laegeforen (1997) 0.75
Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway. Construct Group. Scand J Infect Dis (1996) 0.75
[HIV testing of hospital patients]. Tidsskr Nor Laegeforen (1988) 0.75
[Chlamydia trachomatis. Direct detection with an immunofluorescence test]. Tidsskr Nor Laegeforen (1986) 0.75
Liposome encapsulation of the internal control for whole process quality assurance of nucleic acid amplification-based assays. J Microbiol Methods (2003) 0.75
Infective, chronic carriers of hepatitis C virus among blood donors with no history of clinical hepatitis. Transfus Med (1991) 0.75